Vyant Bio
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.19-3.79-1.68-1.35-1.83-0.32-1.71-0.74-0.66-0.18-0.07-1.83
Price/Sales ratio
9.726.181.880.791.310.241.577.9426.606.182.581.31
Price/Book Value ratio
1.411.821.020.831.420.971.55-0.180.970.410.290.97
Price/Cash Flow ratio
-7.96-5.11-2.49-1.19-2.81-0.52-1.32-1.18-1.79-0.30-0.13-2.81
Price/Free Cash Flow ratio
-7.63-4.56-2.30-1.15-2.55-0.49-1.32-1.17-1.74-0.28-0.13-2.55
Price/Earnings Growth ratio
-0.120.11-0.140.02-1.280.010.02-0.110.010.00-0.00-1.28
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
25.49%17.11%21.85%36.76%37.94%31.83%49.33%-26.98%-60.88%-51.35%35.27%35.27%
Operating Profit Margin
-128.01%-188.33%-118.49%-61.82%-63.94%-66.23%-37.13%-879.23%-1368.11%-2389.18%-2173.28%-66.23%
Pretax Profit Margin
-197.22%-186.21%-118.44%-58.42%-78.84%-74.16%-101.25%-997.69%-1618.03%-2373.42%-2163.84%-74.16%
Net Profit Margin
-187.18%-163.17%-111.88%-58.42%-71.70%-74.16%-91.82%-1060.66%-4015.24%-3406.90%-3320.81%-74.16%
Effective Tax Rate
5.09%12.37%5.54%-8.70%9.05%0.28%6.92%-6.31%-148.15%-43.54%-28.05%0.28%
Return on Assets
-22.43%-35.33%-41.28%-37.24%-39.98%-57.54%-45.00%-227.11%-122.47%-149.22%-247.66%-57.54%
Return On Equity
-27.21%-48.16%-61.13%-61.67%-78.01%-299.51%-90.83%25.23%-147.31%-228.98%-239.46%-299.51%
Return on Capital Employed
-18.18%-44.94%-54.78%-53.28%-57.15%-224.25%-34.20%-381.15%-48.76%-137.88%-213.56%-213.56%
Liquidity Ratios
Current Ratio
6.027.272.852.121.180.341.020.96N/AN/A3.141.18
Quick Ratio
5.927.212.842.101.080.281.020.664.183.122.821.08
Cash ratio
5.735.851.970.860.480.000.550.383.792.732.730.48
Days of Sales Outstanding
90.50179.95133.96158.52137.3493.5134.77163.76137.98177.01103.9693.51
Days of Inventory outstanding
14.7312.083.443.1137.0428.03N/A137.5793.8619.1926.3528.03
Operating Cycle
105.23192.04137.40161.64174.39121.5434.77301.34231.85196.2151.99121.54
Days of Payables Outstanding
N/A-2.54KN/AN/AN/AN/AN/A430.97146.23237.17325.71N/A
Cash Conversion Cycle
105.232.73K137.40161.64174.39121.5434.77-129.6285.61-40.96-215.25121.54
Debt Ratios
Debt Ratio
5.721.390.120.100.120.080.091.960.030.140.340.12
Debt Equity Ratio
6.941.890.180.180.240.420.18-0.210.030.220.530.24
Long-term Debt to Capitalization
0.870.150.120.090.020.050.01-0.250.020.140.140.02
Total Debt to Capitalization
0.870.650.150.150.190.290.15-0.270.030.180.180.29
Interest Coverage Ratio
-3.54-40.62-62.14-36.83-8.75-8.58-1.88-30.08N/AN/A-218.09-8.58
Cash Flow to Debt Ratio
-0.02-0.18-2.27-3.83-2.04-4.38-6.21-0.73-14.19-6.22-9.57-4.38
Company Equity Multiplier
1.211.361.481.651.955.202.01-0.111.201.531.535.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.22-1.20-0.75-0.65-0.46-0.45-1.18-6.70-14.80-20.54-18.53-0.45
Free Cash Flow / Operating Cash Flow Ratio
1.041.121.081.031.101.051.001.011.031.041.011.05
Cash Flow Coverage Ratio
-0.02-0.18-2.27-3.83-2.04-4.38-6.21-0.73-14.19-6.22-9.57-4.38
Short Term Coverage Ratio
-1.34-0.20-10.20-8.92-2.26-5.05-6.78-11.95-51.33-24.21-37.20-5.05
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A